Biofilm-based central line-associated bloodstream infections
- PMID: 25366227
- DOI: 10.1007/978-3-319-11038-7_10
Biofilm-based central line-associated bloodstream infections
Abstract
Different types of central venous catheters (CVCs) have been used in clinical practice to improve the quality of life of chronically and critically ill patients. Unfortunately, indwelling devices are usually associated with microbial biofilms and eventually lead to catheter-related bloodstream infections (CLABSIs).An estimated 250,000-400,000 CLABSIs occur every year in the United States, at a rate of 1.5 per 1,000 CVC days and a mortality rate of 12-25 %. The annual cost of caring for patients with CLABSIs ranges from 296 million to 2.3 billion dollars.Biofilm formation occurs on biotic and abiotic surfaces in the clinical setting. Extensive studies have been conducted to understand biofilm formation, including different biofilm developmental stages, biofilm matrix compositions, quorum-sensing regulated biofilm formation, biofilm dispersal (and its clinical implications), and multi-species biofilms that are relevant to polymicrobial infections.When microbes form a matured biofilm within human hosts through medical devices such as CVCs, the infection becomes resistant to antibiotic treatment and can develop into a chronic condition. For that reason, many techniques have been used to prevent the formation of biofilm by targeting different stages of biofilm maturation. Other methods have been used to diagnose and treat established cases of CLABSI.Catheter removal is the conventional management of catheter associated bacteremia; however, the procedure itself carries a relatively high risk of mechanical complications. Salvaging the catheter can help to minimize these complications.In this article, we provide an overview of microbial biofilm formation; describe the involvement of various genetic determinants, adhesion proteins, organelles, mechanism(s) of biofilm formation, polymicrobial infections, and biofilm-associated infections on indwelling intravascular catheters; and describe the diagnosis, management, and prevention of catheter-related bloodstream infections.
Similar articles
-
Incidence, risk factors, microbiology of venous catheter associated bloodstream infections--a prospective study from a tertiary care hospital.Indian J Med Microbiol. 2015 Apr-Jun;33(2):248-54. doi: 10.4103/0255-0857.153572. Indian J Med Microbiol. 2015. PMID: 25865976
-
The microbial biofilm composition on peripherally inserted central catheters: A comparison of polyurethane and hydrophobic catheters collected from paediatric patients.J Vasc Access. 2021 May;22(3):388-393. doi: 10.1177/1129729820932423. Epub 2020 Jun 22. J Vasc Access. 2021. PMID: 32564705 Clinical Trial.
-
Central venous catheters and biofilms: where do we stand in 2017?APMIS. 2017 Apr;125(4):365-375. doi: 10.1111/apm.12665. APMIS. 2017. PMID: 28407421 Review.
-
Mini-review: Antimicrobial central venous catheters--recent advances and strategies.Biofouling. 2011 Jul;27(6):609-20. doi: 10.1080/08927014.2011.593261. Biofouling. 2011. PMID: 21718230 Review.
-
Analysis of central line-associated bloodstream infections in the intensive care unit after implementation of central line bundles.Infect Control Hosp Epidemiol. 2010 May;31(5):551-3. doi: 10.1086/652157. Infect Control Hosp Epidemiol. 2010. PMID: 20334506
Cited by
-
Functionalized Self-Assembled Monolayers: Versatile Strategies to Combat Bacterial Biofilm Formation.Pharmaceutics. 2022 Aug 2;14(8):1613. doi: 10.3390/pharmaceutics14081613. Pharmaceutics. 2022. PMID: 36015238 Free PMC article. Review.
-
Prospects and challenges for the application of tissue engineering technologies in the treatment of bone infections.Bone Res. 2024 May 14;12(1):28. doi: 10.1038/s41413-024-00332-w. Bone Res. 2024. PMID: 38744863 Free PMC article. Review.
-
Comparative effectiveness of catheter salvage strategies for pediatric catheter-related bloodstream infections.J Pediatr Surg. 2016 Feb;51(2):296-301. doi: 10.1016/j.jpedsurg.2015.10.079. Epub 2015 Nov 6. J Pediatr Surg. 2016. PMID: 26644072 Free PMC article.
-
Enzymatic Transition States and Drug Design.Chem Rev. 2018 Nov 28;118(22):11194-11258. doi: 10.1021/acs.chemrev.8b00369. Epub 2018 Oct 18. Chem Rev. 2018. PMID: 30335982 Free PMC article. Review.
-
Current Clinical Laboratory Challenges to Widespread Adoption of Phage Therapy in the United States.Antibiotics (Basel). 2025 May 29;14(6):553. doi: 10.3390/antibiotics14060553. Antibiotics (Basel). 2025. PMID: 40558145 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources